Yajing Lu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Liver Disease Diagnosis and Treatment 3
-
- RNA Research and Splicing 2
- Co-authors
- Rui Zhou (4 shared papers)Xian‐Ming Chen (2 shared papers)Xiangli Bai (8 shared papers)Xiong Jia (8 shared papers)Si Jin (8 shared papers)Ming-Hong Xie (2 shared papers)Ying Zhao (6 shared papers)Wenzhuo Cheng (6 shared papers)
In The Last Decade
Yajing Lu
21 papers receiving 405 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 134
- Geriatrics and Gerontology 25
- Clinical Biochemistry 28
- Immunology 76
- Physiology 12
Countries citing papers authored by Yajing Lu
This map shows the geographic impact of Yajing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Lu more than expected).
Fields of papers citing papers by Yajing Lu
This network shows the impact of papers produced by Yajing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Lu. The network helps show where Yajing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yajing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 106 | |
| 2 | 2022 | 58 | |
| 3 | 2022 | 33 | |
| 4 | 2019 | 32 | |
| 5 | 2023 | 29 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 22 | |
| 8 | 2020 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2015 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 9 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2017 | 3 | |
| 20 | 2023 | 1 |
About Yajing Lu
Yajing Lu is a scholar working on Epidemiology, Molecular Biology, Cancer Research, Surgery and Immunology, having authored 21 papers that have together received 406 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (4 papers), Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Lipid metabolism and disorders (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (134 citations), Geriatrics and Gerontology (25 citations), Clinical Biochemistry (28 citations), Immunology (76 citations) and Physiology (12 citations). Yajing Lu has collaborated with scholars based in China, Italy and Pakistan. Frequent co-authors include Rui Zhou, Xian‐Ming Chen, Xiangli Bai, Xiong Jia, Si Jin, Ming-Hong Xie, Ying Zhao, Wenzhuo Cheng, Xiaoqing Li and Shu Meng. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, The Journal of Immunology, Metabolism, Scientific Reports and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.